Anders Tidfors new CFO of WntResearch
Anders Tidfors has a strong background including several CFO assignments, both nationally and internationally. With considerable experience from leading financial roles, Tidfors will strengthen WntResearch in executing the Company's clinical programs with the drug candidate Foxy-5. Tidfors will take up appointment in mid-November, initially combining part-time work for WntResearch with other assignments, including work for a listed company."I look forward to continue to develop WntResearch's organization, financial control and positioning together with Anders to implement the company's